Vorasidenib: What is it and what does it mean for you? | Living Well with Brain Cancer
1:33:27
YouTubeUCSF Neurosurgery
Vorasidenib: What is it and what does it mean for you? | Living Well with Brain Cancer
Learn about the latest FDA-approved treatment for low-grade gliomas with mutant IDH1 and IDH2 from UCSF neuro-oncologist, Jennie Taylor, MD. Lynton Daniel offers a first-hand perspective. Introduction by Susan Chang, MD. Sponsored by the UCSF Sheri Sobrato Brain Cancer Survivorship Program. For more information about the Survivorship Program ...
3.3K viewsSep 10, 2024
Related Products
2HG IDH2
Cardiac IDH2
Etnk1 IDH2
#idh2
Early intervention with IDH inhibitors in IDH-mutated MDS: insights from clinical experience
Early intervention with IDH inhibitors in IDH-mutated MDS: insights from clinical experience
YouTube3 months ago
Are There Different Types Of IDH Inhibitors? - Oncology Support Network
Are There Different Types Of IDH Inhibitors? - Oncology Support Network
YouTube5 months ago
Top videos
Outcomes with low-intensity venetoclax in NPM1-mutated AML depend on co-mutational profile
2:26
Outcomes with low-intensity venetoclax in NPM1-mutated AML depend on co-mutational profile
YouTubeVJHemOnc – Video Journal
25 views2 weeks ago
IDH2 Isocitrate Dehydrogenase 2
0:20
IDH2 Isocitrate Dehydrogenase 2
YouTubeStory Lens
2 months ago
IDH2 Mutations Generate Oncometabolite 2-Hydroxyglutarate and Impair Differentiation in Leukemia(1)
3:00
IDH2 Mutations Generate Oncometabolite 2-Hydroxyglutarate and Impair Differentiation in Leukemia(1)
YouTubeStory Lens
3 weeks ago
IDH2 Cancer
Phase I/II study of decitabine, venetoclax, and ivosidenib or enasidenib in IDH-mutated AML
5:18
Phase I/II study of decitabine, venetoclax, and ivosidenib or enasidenib in IDH-mutated AML
YouTubeVJHemOnc – Video Journal
79 views3 months ago
The current standard of care for IDH-mutated AML & combinations being explored
2:54
The current standard of care for IDH-mutated AML & combinations being explored
YouTubeVJHemOnc – Video Journal
20 views3 months ago
Onyee Chan, MD: VEN/HMA vs IDHi as frontline options in IDH-mutated AML
2:05
Onyee Chan, MD: VEN/HMA vs IDHi as frontline options in IDH-mutated AML
YouTubeMoffitt Cancer Center
9 views3 weeks ago